Many initiatives have tried to address this partnership challenge: the Healthcare Communications Association’s (HCA) own ...

Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu ...

Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ...

Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024. At this year’s event, ...

NHS England has announced that hundreds of babies have begun to be tested for over 200 genetic conditions as part of a study led by Genomics England. The Generation Study is evaluating the potential ...

Astellas Pharma’s claudin 18.2-directed cytolytic antibody has been approved by the European Commission (EC) as part of a first-line combination treatment for a subset of gastric cancer patients.

Research on the state of the customer experience (CX) that the global pharmaceutical industry provides to healthcare professionals (HCPs) has been released by DT Consulting, an Indegene company. For ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The ...

The US Food and Drug Administration (FDA) has granted rare paediatric disease (RPD) designation to Enterprise Therapeutics’ investigational cystic fibrosis therapy. Estimated to affect more than ...

During a recent media audit on sickle cell disease, an intriguing pattern emerged that the name ‘Christopher’ was the third most mentioned term. This unexpected finding resonated with me, as I share ...